These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11745918)

  • 1. CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbit.
    Weber A; Kaplan M; Chughtai SA; Cohn LA; Smith AL; Unadkat JD
    Biopharm Drug Dispos; 2001 May; 22(4):157-68. PubMed ID: 11745918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes.
    Reinach B; de Sousa G; Dostert P; Ings R; Gugenheim J; Rahmani R
    Chem Biol Interact; 1999 Jun; 121(1):37-48. PubMed ID: 10418969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
    Li AP; Reith MK; Rasmussen A; Gorski JC; Hall SD; Xu L; Kaminski DL; Cheng LK
    Chem Biol Interact; 1997 Nov; 107(1-2):17-30. PubMed ID: 9402947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog.
    Mae T; Hosoe K; Yamamoto T; Hidaka T; Ohashi T; Kleeman JM; Adams PE
    Xenobiotica; 1998 Aug; 28(8):759-66. PubMed ID: 9741954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6.
    Boek-Dohalská L; Hodek P; Sulc M; Stiborová M
    Chem Biol Interact; 2001 Oct; 138(1):85-106. PubMed ID: 11640917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.
    Greenblatt DJ; von Moltke LL; Daily JP; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1999 Aug; 19(4):293-6. PubMed ID: 10440454
    [No Abstract]   [Full Text] [Related]  

  • 10. Triazolam is ineffective in patients taking rifampin.
    Villikka K; Kivistö KT; Backman JT; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Jan; 61(1):8-14. PubMed ID: 9024169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene.
    Lehman-McKeeman LD; Johnson DR; Caudill D
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):169-77. PubMed ID: 9007046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.
    Perloff MD; von Moltke LL; Cotreau MM; Greenblatt DJ
    Biochem Pharmacol; 1999 Jun; 57(11):1227-32. PubMed ID: 10230766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rifampicin-induced hepatic microsomal enzyme system for the generation of cyclosporine metabolites.
    Tamolang MB; Liu WT; Pang H; Ren Y; Wong PY
    Pharmacol Res; 1995 Sep; 32(3):141-8. PubMed ID: 8745344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of human hepatocyte cultures to study the induction of cytochrome P-450.
    Kostrubsky VE; Ramachandran V; Venkataramanan R; Dorko K; Esplen JE; Zhang S; Sinclair JF; Wrighton SA; Strom SC
    Drug Metab Dispos; 1999 Aug; 27(8):887-94. PubMed ID: 10421615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the metabolism of midazolam by rifampin in cultured porcine hepatocytes: preliminary evidence for CYP3A isoforms in pigs.
    Hosagrahara VP; Hansen LK; Remmel RP
    Drug Metab Dispos; 1999 Dec; 27(12):1512-8. PubMed ID: 10570035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodarone.
    Kozlik P; Ha HR; Stieger B; Bigler L; Follath F
    Xenobiotica; 2001 May; 31(5):239-48. PubMed ID: 11491386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytochromes P-450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdine.
    Diamond S; Rakestraw D; O'Neil J; Lam GN; Christ DD
    Drug Metab Dispos; 1994; 22(1):65-73. PubMed ID: 8149892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.
    Strolin Benedetti M; Dostert P
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):101-5. PubMed ID: 7698069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.